Optimized methods to image hepatic lipid droplets in zebrafish larvae
The optical transparency of zebrafish larvae enables visualization of subcellular structures in intact organs, and these vertebrates are widely used to study lipid biology and liver disease. Lipid droplet (LD) presence is a prevalent feature of healthy cells, but, under conditions such as nutrient e...
Saved in:
Published in | Disease models & mechanisms Vol. 17; no. 11 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
England
The Company of Biologists Ltd
01.11.2024
The Company of Biologists |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The optical transparency of zebrafish larvae enables visualization of subcellular structures in intact organs, and these vertebrates are widely used to study lipid biology and liver disease. Lipid droplet (LD) presence is a prevalent feature of healthy cells, but, under conditions such as nutrient excess, toxicant exposure or metabolic imbalance, LD accumulation in hepatocytes can be a harbinger of more severe forms of liver disease. We undertook a comprehensive analysis of approaches useful to investigate LD distribution and dynamics in physiological and pathological conditions in the liver of zebrafish larvae. This comparative analysis of the lipid dyes Oil Red O, Nile Red, LipidTox and LipidSpot, as well as transgenic LD reporters that rely on EGFP fusions of the LD-decorating protein perilipin 2 (PLIN2), demonstrates the strengths and limitations of each approach. These protocols are amenable to detection methods ranging from low-resolution stereomicroscopy to confocal imaging, which enables measurements of hepatic LD size, number and dynamics at cellular resolution in live and fixed animals. This resource will benefit investigators studying LD biology in zebrafish disease models. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Handling Editor: E. Elizabeth Patton These authors contributed equally to this work Competing interests The authors declare no competing or financial interests. Present address: Icon Biotech, 644 Chapel Street, South Yarra, VIC 3141, Australia. |
ISSN: | 1754-8403 1754-8411 1754-8411 |
DOI: | 10.1242/dmm.050786 |